Frazier Financial Advisors, LLC Neurocrine Biosciences Inc Transaction History
Frazier Financial Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 70 shares of NBIX stock, worth $9,732. This represents 0.01% of its overall portfolio holdings.
Number of Shares
70
Previous 70
-0.0%
Holding current value
$9,732
Previous $9.64 Million
16.3%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.97 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.39 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$716 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$358 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$259 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...